Adelqui Peralta MD
Adjunct Instructor, Cardiovascular Medicine
72 E. Concord Street adelqui.peralta@va.gov
Sections
Cardiovascular Medicine
Biography
Dr. Adelqui Peralta, MD is a clinical cardiac electrophysiologist in West Roxbury, MA. He graduated from Facultad De Medicina University Nat'l De Rosario and specializes in clinical cardiac electrophysiology.
Education
MD, Facultad de Ciencias Médicas
Publications
Qian X, Zei PC, Osorio J, Hincapie D, Gabr M, Peralta A, Miranda-Arboleda AF, Koplan BA, Hoyos C, Matos CD, Lopez-Cabanillas N, Steiger NA, Velasco A, Alviz I, Kapur S, Tadros TM, Tedrow UB, Sauer WH, Romero JE. Lesion characteristics using high-frequency low-tidal volume ventilation versus standard ventilation during ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2024 Oct; 35(10):1962-1971. PMID: 39113311.
Published on 4/10/2024Backman WD, DiCaro MV, Zuo X, Peralta A, Orkaby AR. Aligning goals with care: Advance directives in older adults with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol. 2024 May; 47(5):697-701. PMID: 38597183.
Published on 2/13/2024Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis. J Cardiovasc Electrophysiol. 2024 Apr; 35(4):715-726. PMID: 38348517.
Published on 10/19/2023Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP. Persistence of significant secondary mitral regurgitation post-cardiac resynchronization therapy and survival: a systematic review and meta-analysis : Mitral regurgitation and mortality post-CRT. Heart Fail Rev. 2024 Jan; 29(1):165-178. PMID: 37855988.
Published on 1/22/2023Diaz JC, Cañas F, Duque M, Aristizabal J, Niño C, Bastidas O, Marin J, Rivera E, Hoyos C, Matos C, Peralta A, Martin DT, Romero J. Assisted reality device to guide cardiac implantable device programming in distant rural areas. J Cardiovasc Electrophysiol. 2023 Mar; 34(3):497-501. PMID: 36640437.
Published on 8/6/2021Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo Tcheugui JB, Martin DT, Joseph J, Singh JP. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis. Europace. 2021 08 06; 23(8):1262-1274. PMID: 33496319.
Published on 2/6/2021Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo-Tcheugui JB, Martin DT, Joseph J, Singh JP. Ongoing Risk of Ventricular Arrhythmias and All-Cause Mortality at Implantable Cardioverter Defibrillator Generator Change: A Systematic Review and Meta-Analysis. Circ Arrhythm Electrophysiol. 2021 03; 14(3):e009139. PMID: 33554611.
Published on 5/12/2018Ofman P, Hoffmeister P, Kaloupek DG, Gagnon DR, Peralta A, Djousse L, Gaziano JM, Rahilly-Tierney CR. Posttraumatic stress disorder and mortality in VA patients with implantable cardioverter-defibrillators. Clin Cardiol. 2018 May; 41(5):652-659. PMID: 29532498.
Published on 6/30/2014Ofman P, Petrone AB, Peralta A, Hoffmeister P, Albert CM, Djousse L, Gaziano JM, Rahilly-Tierney CR. Aspirin use and risk of atrial fibrillation in the Physicians' Health Study. J Am Heart Assoc. 2014 Jun 30; 3(4). PMID: 24980132.
Published on 6/30/2013Ofman P, Peralta A, Hoffmeister P, Gaziano JM, Djousse L. Do Omega-3 Fatty Acids Decrease the Incidence of Atrial Fibrillation? J Atr Fibrillation. 2013 Jun-Jul; 6(1):836. PMID: 28496856.